- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Trametinib (GSK1120212)
Total 278 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | KRAS Gene Mutation | Metastatic Malignant Solid Neoplasm | EGFR Gene Mutation | ERBB2 Gene Amplification | ERBB2 Gene Mutation | EGFR Gene Amplification | ERBB3 Gene Mutation | ERBB4 Gene MutationUnited States
-
PfizerCompletedBreast Neoplasms | Metastatic Breast CancerUnited States
-
GlaxoSmithKlineWithdrawn
-
Se Jun ParkRecruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingStudy of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid CancerThyroid Cancer | Anaplastic Thyroid Cancer | BRAF Gene Mutation | BRAF Mutation-Related TumorsUnited States
-
GlaxoSmithKlineCompletedNeoplasms | CancerUnited Kingdom, France
-
Novartis PharmaceuticalsTerminatedSolid Tumors for Phase Ib | Pancreatic Cancer for Phase II | Colorectal Cancer for Phase IIUnited States, Canada, Australia, Belgium, Germany, Netherlands, Spain
-
Sarcoma Alliance for Research through CollaborationNovartisWithdrawnGastrointestinal Stromal Tumors
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
Fondazione Melanoma OnlusWithdrawn
-
Canadian Cancer Trials GroupNovartisTerminatedMelanoma | Brain MetastasesCanada
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Oxford; National Institute for Health Research, United Kingdom; Oxford University Hospitals NHS TrustCompleted
-
MelanomaPRO, RussiaNovartisRecruitingMelanoma | Melanoma Stage IV | Melanoma Stage IIIRussian Federation
-
Novartis PharmaceuticalsWithdrawn
-
GlaxoSmithKlinePfizerCompleted
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Changhai HospitalCompleted
-
National Cancer Centre, SingaporeRecruitingColorectal Cancer | Pancreatic AdenocarcinomaSingapore
-
Massachusetts General HospitalNovartis; Barbara Ann Karmanos Cancer Institute; Multiple Myeloma Research ConsortiumRecruitingA Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedCancerFrance, Australia, United States, Canada, United Kingdom
-
Novartis PharmaceuticalsCompletedMalignant MelanomaCanada, Italy, Czechia, Australia, France, Greece, Israel, Russian Federation, Sweden, United Kingdom, Hungary, Slovakia, Slovenia, Japan, Turkey, Argentina, Finland, Norway, Brazil, Latvia, Lithuania, Poland, Portugal
-
University of CologneCompletedBronchial NeoplasmsSpain, Germany
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Novartis PharmaceuticalsCompletedMelanoma and Brain MetastasesCanada, United States, Australia, France, Germany, Italy, Spain
-
Clovis Oncology, Inc.Novartis PharmaceuticalsTerminated
-
Collin BlakelyNovartisRecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IV Lung CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingMelanomaItaly, Belgium, Germany, Argentina, Australia, France, Israel, Netherlands, Switzerland, United States, United Kingdom, Norway
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Thyroid Gland Carcinoma | Poorly Differentiated Thyroid Gland Carcinoma | Refractory Thyroid Gland Carcinoma | Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 | Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IVA Thyroid... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Malignant Solid NeoplasmUnited States
-
C4 Therapeutics, Inc.RecruitingMelanoma | NSCLC | Solid Tumors | CRC | ATCUnited States, Spain, France
-
Novartis PharmaceuticalsTerminatedMelanoma | Non-Small Cell Lung CancerItaly, Australia, Belgium, Germany, Spain, Korea, Republic of, Israel, France, United States, Sweden, Poland
-
University of California, San FranciscoNovartis Pharmaceuticals; University of California, DavisTerminatedNon-small Cell Lung CancerUnited States
-
Prof. Dr. med. Dirk SchadendorfTerminatedMalignant MelanomaGermany
-
Universitair Ziekenhuis BrusselCompletedStage IV Melanoma | Stage III MelanomaBelgium
-
University Health Network, TorontoCompletedColorectal Cancer | KRAS Wildtype | NRAS Wildtype | BRAF WildtypeCanada
-
Novartis PharmaceuticalsActive, not recruitingCarcinoma, Non-Small-Cell LungChina
-
Massachusetts General HospitalIncyte CorporationTerminated
-
Dana-Farber Cancer InstituteNovartisActive, not recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedLiver Cancer | Hepatocellular CancerUnited States
-
MedImmune LLCCompletedMelanomaItaly, United States, Canada, France
-
National Cancer Institute (NCI)TerminatedStage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7United States
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingHepatocellular Carcinoma | Solid Tumor, AdultChina
-
University of ArkansasWithdrawn
-
Erasca, Inc.RecruitingAdvanced or Metastatic Solid TumorsUnited States, Korea, Republic of, Canada, United Kingdom, Australia
-
University College, LondonRecruitingOvarian CancerAustralia, United Kingdom, Canada, New Zealand
-
National Cancer Institute (NCI)WithdrawnDabrafenib and Trametinib in Treating Patients With Erdheim Chester Disease With BRAF V600 MutationsErdheim-Chester DiseaseUnited States
-
National Cancer Institute (NCI)Active, not recruitingRefractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsActive, not recruitingMelanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedLung Cancer | Lung Cancer Metastatic | Lung Adenocarcinoma | Lung Cancer Stage IV | Recurrent Lung Adenocarcinoma | Recurrent Lung CancerUnited States